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Prevention: Toward a Golden Age
Jean-Claude Pechère, MD
Editorial
According to the World Health Organization report-
ing office, approximately 52 million human beings died in
1996, including 17 million from infectious diseases, 14 mil-
lion from cardiovascular conditions, and 6 million from
cancer. In 1990 also, there were 17 million deaths by infec-
tion. Today, compared to 10 years ago, we have fewer res-
piratory and diarrheal diseases, less measles, but more
tuberculosis (approximately 3 million deaths in 1997,
including an increasing number of multidrug-resistant
cases), hepatitis B (600,000 deaths in 1997), malaria (prob-
ably more than 2 million deaths in 1997, with the increas-
ing burden of resistance to antimalarial remedies), and
acquired immunodeficiency syndrome (2,300,000 deaths in
1997). Vancomycin-resistant enterococci, the progressing
epidemic of penicillin-resistant pneumococci in the United
States, and the increasing number of extended-spectrum b-
lactamases illustrate our failure to overcome bacterial
antibiotic resistance in developed areas, despite the devel-
opment of potent new antibacterial agents. In nondevel-
oped areas, the situation often is even worse, and preva-
lence of methicillin-resistant Staphylococcus aureus or mul-
tidrug-resistant pneumococci may surpass 50%. In some
privileged, modern, well-equipped institutions, vigorous
efforts have maintained an acceptable control of horizontal
transmission, but this is not the case in many other places,
and nosocomial infections remain a fatal trap for an
unknown number of people, probably much higher than
we think, in the poorest countries of the world. Life
expectancy is progressing in the richest countries, where
our populations are getting older, hence more susceptible
to cancers and cardiovascular diseases, which bring their
concomitant risks of infections. The implication of micro-
bial agents in diseases that were not thought to be infec-
tious is more and more often recognized or suspected:
Helicobacter pylori in peptic ulcer, retrovirus and super-
antigen pathogenesis in diabetes and multiple sclerosis,
Borna disease virus infection in patients with neuropsychi-
atric disorders, and Chlamydia pneumoniae in severe com-
plications of coronary heart disease are just examples of
this situation. Recent data suggest that a variety of syn-
dromes are triggered by acute infectious illnesses, eg,
Campylobacter jejuni in Guillain-Barré‚ syndrome. The list
of new agents causing infectious diseases lengthens regu-
larly. Altogether, from the public-health viewpoint, we do
not progress much, one step forward here, one step back-
ward there. 
For meeting the challenge, no magic drugs can be
predicted in the foreseeable future, and drug therapy prob-
ably will not be the solution. However, new tools are
becoming available that open many new avenues in pre-
vention. Research on vaccines has been extraordinarily
active and fruitful in the recent years, signaling an actual
revolution in the domain. We have learned to design three-
dimensional epitopes; to stimulate immune responses
towards the most effective directions, depending on the
targeted pathogen; and to understand how to elicit long-
term immunological memory. Ongoing promising develop-
ments are seen in the area of therapeutic vaccines, to be
given to asymptomatic-infected individuals before they get
sick. Nucleic-acid vaccines, molecular vaccines, microen-
capsulated vaccines, new adjuvants, mucosal vaccines, vec-
tored vaccines, and edible vaccines are paving the way of
products easy to make, for a few cents per dose, easy to
administer, stable. Tomorrow, immunization could be as
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easy and as cheap as eating a banana. The vaccine pipeline
now includes products aimed at protecting against dis-
eases for which no immunizations are presently available,
such as rotavirus, the most common cause of severe diar-
rhea among children, or H pylori, associated with peptic
ulcer and stomach cancer. In the future, the new vaccine
targets may include cancer (cervical neoplasm associated
with human papillomavirus infection, as well as vaccines
targeted at a variety of tumor-associated antigens) and
autoimmune diseases.
Predictive medicine is aiming at the recognition at a
pre-clinical stage of genetic configurations predisposing to
diseases or defects. Some of these methods permit the
detection of such disorders in the fetus during gestation.
This should enable us to develop effective preventive mea-
sures before the appearance of complications. Such
approaches are used already for the early detection of clas-
sic patterns of genetic diseases, but can be extended to a
great number of conditions out of the classic pattern, from
diabetes to cancer to arterial hypertension. Even infectious
diseases, which used to be a paradigm of exogenous
causality, are modulated by genes of resistance or suscep-
tibility. In a more distant future, when the human genome
is sequenced and it is possible to define accurately the
genetic risks for certain conditions favoring infectious dis-
eases, it may be conceivable to define new strategies for
vaccines.
Epidemiology also is progressing rapidly. Computer-
assisted molecular identification of microorganisms has
achieved a degree of discrimination allowing a truly clonal
epidemiology. Sophisticated mathematical models now are
able to predict new epidemiological trends accurately,
offering a potent tool for setting active preventive mea-
sures. The computer revolution also will help us to take up
the immense challenge of education. Prevention is, first,
education. Easy and rapid access to information is a key
feature. There is no doubt that the new communication net-
works represent a fantastic advantage for disseminating
information in the most remote areas of the world. 
The challenge of infectious diseases remains
immense, but new concepts and new tools augment con-
siderably our armamentarium for improved prophylactic
measures: the 21st century may well be a golden age for
prevention. 
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